
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD‐L1/VEGFA Axis
Jingyuan Wen, Xue Lin, Wei Yi, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 26
Jingyuan Wen, Xue Lin, Wei Yi, et al.
Advanced Science (2024) Vol. 11, Iss. 13
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
E-twenty-six-specific sequence variant 5 (ETV5) facilitates hepatocellular carcinoma progression and metastasis through enhancing polymorphonuclear myeloid-derived suppressor cell (PMN-MDSC)-mediated immunosuppression
Zerui Zhang, Wenjie Huang, Dian Hu, et al.
Gut (2025), pp. gutjnl-333944
Closed Access | Times Cited: 1
Zerui Zhang, Wenjie Huang, Dian Hu, et al.
Gut (2025), pp. gutjnl-333944
Closed Access | Times Cited: 1
Role of m6A modifications in immune evasion and immunotherapy
Chunyu Wu, Lvyuan Li, Qiling Tang, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 6
Chunyu Wu, Lvyuan Li, Qiling Tang, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 6
m6A modification of VEGFA mRNA by RBM15/YTHDF2/IGF2BP3 contributes to angiogenesis of hepatocellular carcinoma
Xiaoxin Xu, Shuxiang Wu, Yi Zhang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 11, pp. 2174-2189
Closed Access | Times Cited: 4
Xiaoxin Xu, Shuxiang Wu, Yi Zhang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 11, pp. 2174-2189
Closed Access | Times Cited: 4
The YTH domain‐containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets
Fenghe Li, Chong Zeng, Jie Liu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 4
Fenghe Li, Chong Zeng, Jie Liu, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 4
Biological functions of 5-methylcytosine RNA-binding proteins and their potential mechanisms in human cancers
Tingting Zhao, Zhe Zhang, Zhuo Chen, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Tingting Zhao, Zhe Zhang, Zhuo Chen, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy
Yong Li, Qingbin Liu, Xianying Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yong Li, Qingbin Liu, Xianying Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes
Tongguo Shi, Huan Zhang, Yueqiu Chen
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Tongguo Shi, Huan Zhang, Yueqiu Chen
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
NAD+ Metabolism Reprogramming Drives SIRT1‐Dependent Deacetylation Inducing PD‐L1 Nuclear Localization in Cervical Cancer
Xinyi Lu, Pingping Jin, Qianyun Tang, et al.
Advanced Science (2025)
Open Access
Xinyi Lu, Pingping Jin, Qianyun Tang, et al.
Advanced Science (2025)
Open Access
The role of YTHDF2 in anti-tumor immunity
Leying Zhang, Cunte Chen, Jia Feng, et al.
Cell investigation. (2025) Vol. 1, Iss. 1, pp. 100008-100008
Open Access
Leying Zhang, Cunte Chen, Jia Feng, et al.
Cell investigation. (2025) Vol. 1, Iss. 1, pp. 100008-100008
Open Access
Naringenin: a potential therapeutic agent for modulating angiogenesis and immune response in hepatocellular carcinoma
Wenmei Wu, Xiangyu Qiu, Xiaofan Ye, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101254-101254
Open Access
Wenmei Wu, Xiangyu Qiu, Xiaofan Ye, et al.
Journal of Pharmaceutical Analysis (2025), pp. 101254-101254
Open Access
Emerging importance of m6A modification in liver cancer and its potential therapeutic role
Tao Chen, Wufei Ye, Songsen Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189299-189299
Closed Access
Tao Chen, Wufei Ye, Songsen Gao, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189299-189299
Closed Access
Harnessing Immunotherapy for Hepatocellular Carcinoma: Principles and Emerging Promises
Hossein Miri, Payman Rahimzadeh, Mehrdad Hashemi, et al.
Pathology - Research and Practice (2025), pp. 155928-155928
Closed Access
Hossein Miri, Payman Rahimzadeh, Mehrdad Hashemi, et al.
Pathology - Research and Practice (2025), pp. 155928-155928
Closed Access
Zengmian Yiliu formula suppresses cell cycle in immune-rich ovarian cancer patient-derived organoids
Qi Cao, Chunhui Cai, Chen Wang, et al.
Phytomedicine (2025) Vol. 141, pp. 156721-156721
Closed Access
Qi Cao, Chunhui Cai, Chen Wang, et al.
Phytomedicine (2025) Vol. 141, pp. 156721-156721
Closed Access
The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma
Gregory Kenneth Muliawan, Terence K. Lee
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Gregory Kenneth Muliawan, Terence K. Lee
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Regulatory effect of N6-methyladenosine on tumor angiogenesis
Yuyan, Enwu Yuan
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Yuyan, Enwu Yuan
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
YTHDF2 promotes anaplastic thyroid cancer progression by activating the DDIT4/AKT/mTOR signaling pathway
Bao Dai, Lei Xu, Shikuo Rong, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Bao Dai, Lei Xu, Shikuo Rong, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 2
Decoding the Role of O-GlcNAcylation in Hepatocellular Carcinoma
Xinyu Zhou, Sirui Hang, Qingqing Wang, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 908-908
Open Access | Times Cited: 1
Xinyu Zhou, Sirui Hang, Qingqing Wang, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 908-908
Open Access | Times Cited: 1
YTHDF2 phase separation promotes arsenic-induced keratinocyte transformation in a poly-m6A-dependent manner by inhibiting translational initiation of the key tumor suppressor PTEN
Tianhe Zhao, Wenxiao Xiong, Jingting Cai, et al.
Journal of Hazardous Materials (2024) Vol. 480, pp. 136243-136243
Closed Access | Times Cited: 1
Tianhe Zhao, Wenxiao Xiong, Jingting Cai, et al.
Journal of Hazardous Materials (2024) Vol. 480, pp. 136243-136243
Closed Access | Times Cited: 1
N6-methyladenosine regulators in hepatocellular carcinoma: investigating the precise definition and clinical applications of biomarkers
Xiaokai Yan, Yao Qi, Xinyue Yao, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Xiaokai Yan, Yao Qi, Xinyue Yao, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Pan-cancer analysis of the potential of PEA3 subfamily genes as tumor markers
Leying Guan, Rong Zeng, Yi Chen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Leying Guan, Rong Zeng, Yi Chen, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Breaking Barriers: Nucleic Acid Aptamers in Gastrointestinal (GI) Cancers Therapy
Herlina Uinarni, Enwa Felix Oghenemaro, Soumya V. Menon, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1763-1776
Closed Access
Herlina Uinarni, Enwa Felix Oghenemaro, Soumya V. Menon, et al.
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 1763-1776
Closed Access
Precision Delivery of Binary Cooperative Nanodrugs Self-Assembled by Berberine Glycyrrhetinic Acid Salts for Hepatocellular Carcinoma Treatment
Xiao Yang, A. Ouyang, Ling Fan, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 43, pp. 58489-58505
Closed Access
Xiao Yang, A. Ouyang, Ling Fan, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 43, pp. 58489-58505
Closed Access
YTHDF2 promotes anaplastic thyroid cancer progression via activating the DDIT4/AKT/mTOR signaling
Bao Dai, Lei Xu, Shikuo Rong, et al.
Research Square (Research Square) (2024)
Open Access
Bao Dai, Lei Xu, Shikuo Rong, et al.
Research Square (Research Square) (2024)
Open Access
m6A and beyond: RNA modifications shaping angiogenesis
Yu Luan, Renbing Jia, Peiwei Chai, et al.
Trends in Molecular Medicine (2024)
Closed Access
Yu Luan, Renbing Jia, Peiwei Chai, et al.
Trends in Molecular Medicine (2024)
Closed Access